These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33027605)

  • 41. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19.
    Li G; He X; Zhang L; Ran Q; Wang J; Xiong A; Wu D; Chen F; Sun J; Chang C
    J Autoimmun; 2020 Aug; 112():102463. PubMed ID: 32303424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.
    Zhao Y; Zhao Z; Wang Y; Zhou Y; Ma Y; Zuo W
    Am J Respir Crit Care Med; 2020 Sep; 202(5):756-759. PubMed ID: 32663409
    [No Abstract]   [Full Text] [Related]  

  • 44. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
    Rathore JS; Ghosh C
    Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32840560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?
    Soldo J; Heni M; Königsrainer A; Häring HU; Birkenfeld AL; Peter A
    Diabetes Care; 2020 Oct; 43(10):e134-e136. PubMed ID: 32753456
    [No Abstract]   [Full Text] [Related]  

  • 46. ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19.
    Lupi L; Adamo M; Inciardi RM; Metra M
    Eur Heart J; 2020 Sep; 41(33):3200. PubMed ID: 32691039
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.
    Monteil V; Kwon H; Prado P; Hagelkrüys A; Wimmer RA; Stahl M; Leopoldi A; Garreta E; Hurtado Del Pozo C; Prosper F; Romero JP; Wirnsberger G; Zhang H; Slutsky AS; Conder R; Montserrat N; Mirazimi A; Penninger JM
    Cell; 2020 May; 181(4):905-913.e7. PubMed ID: 32333836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19, diabetes mellitus and ACE2: The conundrum.
    Pal R; Bhansali A
    Diabetes Res Clin Pract; 2020 Apr; 162():108132. PubMed ID: 32234504
    [No Abstract]   [Full Text] [Related]  

  • 49. Expression of ACE2, the SARS-CoV-2 Receptor, and TMPRSS2 in Prostate Epithelial Cells.
    Song H; Seddighzadeh B; Cooperberg MR; Huang FW
    Eur Urol; 2020 Aug; 78(2):296-298. PubMed ID: 32418620
    [No Abstract]   [Full Text] [Related]  

  • 50. Expression of the SARS-CoV-2
    Zhang H; Rostami MR; Leopold PL; Mezey JG; O'Beirne SL; Strulovici-Barel Y; Crystal RG
    Am J Respir Crit Care Med; 2020 Jul; 202(2):219-229. PubMed ID: 32432483
    [No Abstract]   [Full Text] [Related]  

  • 51. Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2).
    Masood N; Malik SS; Raja MN; Mubarik S; Yu C
    Front Cell Infect Microbiol; 2020; 10():499. PubMed ID: 32974224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19, ACE2, and the cardiovascular consequences.
    South AM; Diz DI; Chappell MC
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1084-H1090. PubMed ID: 32228252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
    Pérez-Vizcaíno F
    J Heart Lung Transplant; 2020 Oct; 39(10):1167-1169. PubMed ID: 32762876
    [No Abstract]   [Full Text] [Related]  

  • 55. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
    Damas J; Hughes GM; Keough KC; Painter CA; Persky NS; Corbo M; Hiller M; Koepfli KP; Pfenning AR; Zhao H; Genereux DP; Swofford R; Pollard KS; Ryder OA; Nweeia MT; Lindblad-Toh K; Teeling EC; Karlsson EK; Lewin HA
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22311-22322. PubMed ID: 32826334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?
    Garg M; Christensen B; Lubel JS
    Gastroenterology; 2020 Oct; 159(4):1623-1624.e3. PubMed ID: 32353370
    [No Abstract]   [Full Text] [Related]  

  • 59. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
    Sawalha AH; Zhao M; Coit P; Lu Q
    Clin Immunol; 2020 Jun; 215():108410. PubMed ID: 32276140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of angiotensin-converting enzyme 2 receptors for severe acute respiratory syndrome coronavirus 2 (COVID-19) on peripheral small-fiber sensory neurons is unknown today.
    Oaklander AL
    Pain; 2020 Nov; 161(11):2431-2433. PubMed ID: 32826753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.